Table 2.
All |
Neoadjuvant = No |
Neoadjuvant = Yes |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | N | Mean | SD | p-Value | |
Physical well-being | 123 | 19.7 | 5.6 | 93 | 19.3 | 5.7 | 30 | 20.9 | 5.0 | 0.184 |
Functional well-being | 123 | 14.3 | 6.1 | 93 | 13.7 | 6.1 | 30 | 16.2 | 6.0 | 0.048 |
Additional concerns | 123 | 31.6 | 6.6 | 93 | 30.7 | 6.5 | 30 | 34.2 | 6.4 | 0.012 |
FACT-O-TOI | 123 | 65.6 | 15.6 | 93 | 63.8 | 15.5 | 30 | 71.3 | 14.7 | 0.020 |
Abdominal discomfort | 123 | 11.1 | 3.7 | 93 | 10.9 | 3.8 | 30 | 11.6 | 3.4 | 0.376 |
Neurotoxicity/ | 123 | 14.8 | 2.0 | 93 | 15.1 | 1.8 | 30 | 14.1 | 2.5 | 0.020 |
neuropathy (high is good) | ||||||||||
Fatigue (high = bad) | 123 | 19.2 | 8.9 | 93 | 19.6 | 9.1 | 30 | 18.0 | 8.3 | 0.396 |